Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, SING GEORGE L, holds the title of Director at REGENERON PHARMACEUTICALS, INC..
On 2026-11-16, the insider transacted 2,000 shares.The shares were transacted at a weighted average price of $958.97 per share, resulting in a total market-relevant value of $1.9M.
SING GEORGE L (Director) sold $1.9M of $REGN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.